ACI
TAK icon

AMP Capital Investors’s Takeda Pharmaceutical TAK Stock Holding History

AMP Capital Investors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,470
Closed -$553K – 1321
2020
Q3 		$553K Buy
+30,470
New +$555K ﹤0.01% 912
2019
Q2 		– Sell
-16,152
Closed -$334K – 1235
2019
Q1 		$334K Sell
16,152
-104,616
-87% -$2.11M ﹤0.01% 1039
2018
Q4 		$2.02M Buy
+120,768
New +$2.04M 0.01% 717

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

AMP Capital Investors's TAK Position: Q4 2020 in Review

AMP Capital Investors sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 30,470 shares — an estimated $553K sold.

AMP Capital Investors first reported a position in TAK in Q4 2018 and held it in 3 quarters. The position peaked at $2.02M in Q4 2018. 313 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

  • AMP Capital Investors reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • AMP Capital Investors sold 30,470 Takeda Pharmaceutical shares in Q4 2020, an estimated $553K.
  • AMP Capital Investors first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 3 quarters.
  • AMP Capital Investors's Takeda Pharmaceutical position peaked at $2.02M in Q4 2018.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on AMP Capital Investors's 13F filing for Q4 2020, filed 12 Feb 2021.